Skip to main content
Caplight Logo









Urchinomics

Urchinomics

Private
Halifax, Nova ScotiaEnergy & Sustainabilityhttps://urchinomics.com/

Last Round

Strategic

Nov 12, 2025

Total Funding Raised

$5.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Urchinomics is a restorative aquaculture company that turns ecologically destructive sea urchins into premium seafood products, helping to restore kelp forests.

Sector

Energy & Sustainability

Verticals

Circular Economy, Biotechnology, Supply Chain, Carbon Capture

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Non-AI

Keywords

restorative aquacultureurchin ranchingkelp forest restorationpremium uniuni farmingsea urchin roesustainable seafoodblue carbon creditsland-based aquacultureurchin barrenscircular economywaste to valueRAS aquacultureblue carbonbiowaste productsecosystem restoration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Urchinomics Comparables

Compare Urchinomics with similar companies based on industry and business-model similarity.

Urchinomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kita-Sanriku Factory INC.
90%
The Oyster Restoration Company
63%
Pine Island Redfish
58%

Urchinomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicNov 12, 2025
StrategicJul 24, 2024
StrategicJul 23, 2024
StrategicJan 19, 2023
Series AMar 30, 2021

Key People

Founding team and executive leadership

Perry Bevin

Chief Executive Officer

Executive Team

Urchinomics Investors

Notable investors and investment history

Urchinomics investors
InvestorRounds
Nippon Yusen Kabushiki KaishaStrategic
Builders VisionSeries A
Cadman Capital GroupStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 55% MoM, reaching 3.3K.

  • May 15, 2026

    Monthly visitors increased 33% MoM, reaching 2.2K.

Urchinomics Filings

Explore SEC and related filing metadata, where available.

Urchinomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Urchinomics's valuation, stock price, and market status.

Is Urchinomics a public or private company?

Urchinomics is a private company.

What is the current stock price of Urchinomics?

Urchinomics is a private company with no public stock price. No recent secondary market data is available.

How much is Urchinomics worth (valuation)?

Valuation information for Urchinomics is not publicly available.

Can I buy Urchinomics stock?

Urchinomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Urchinomics's last funding round?

Urchinomics's most recent funding round was Strategic on November 12, 2025.

Who are the main investors in Urchinomics?

Key investors in Urchinomics include Cadman Capital Group.

Will Urchinomics IPO soon?

No public IPO plans have been announced for Urchinomics.

How can I track Urchinomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Urchinomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHalifax, Nova Scotia
Employee Range10
Year Founded2017
Last FundingNov 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?